Serum tumor markers (TMs) such as carcinoembryonic antigen (CEA), cytokeratin-19 fragment (CYFRA21-1) and neuron-specific enolase (NSE) are routinely tested for diagnosis and prognosis of LC for their easy application [13]. The gene discussed is ENO2; the disease is laryngotracheoesophageal cleft.